BLFS logo

BioLife Solutions (BLFS)

Profile

Full Name

BioLife Solutions, Inc.

Ticker Symbol

BLFS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

November 22, 1989

Indexes

Not included

Website

http://www.biolifesolutions.com

Employees

159

Key Details

Price

$22.44

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$82.25M(+8.44% YoY)

Annual EPS

-$0.44(+71.61% YoY)

PE Ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$22.44
BLFS price is $22.44

Price All-time High

$1365.00
BLFS price is currently -98.36% below its historical high of $1365.00

Price Most Recent Change

-5.63%
BLFS price was down -5.63% on Apr 3, 2025

Price YTD Change

-14.81%
BLFS price is down -14.81% since January 1st

Price 1-year Change

+26.99%
BLFS price is up +26.99% year-on-year

Price 3-year Change

-5%
BLFS price is down -5% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$1.05B
BLFS market capitalization is $1.05 billion

Market Cap 3-year Change

+5.27%
BLFS market capitalization is up +5.27% over the past 3 years

Market Cap All-time High

$2.49B
BLFS market capitalization is currently -57.80% below its historical high of $2.49 billion

Market Cap Sector Rank

76.62%
BLFS market capitalization is higher than 76.62% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.66%
BLFS shares outstanding is up +2.66% year-on-year

Shares Outstanding 3-Year Change

+10.81%
BLFS shares outstanding is up +10.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.38
BLFS beta is 1.38

200-day SMA

$24.71
BLFS price is currently -9.18% below its 200-day simple moving average

50-day SMA

$26.01
BLFS price is currently -13.71% below its 50-day simple moving average

RSI

37.09
BLFS 14-day relative strength index is 37.09

Volume

1.39
BLFS 30-day relative volume is 1.39

ATR

$1.58
BLFS average true range is $1.58

10-day Historical Volatility

80.31%
BLFS 10-day historical volatility is 80.31%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$82.25M
BLFS annual revenue is $82.25 million

Revenue Analysts Estimate

$97.03M
BLFS annual revenue is currently -15.23% lower than the consensus analysts' forecast

Revenue 1-year Change

+8.44%
BLFS annual revenue is up +8.44% year-on-year

Revenue Sector Rank

55.71%
BLFS annual revenue is higher than 55.71% of companies in Healthcare sector

EPS

EPS

-$0.44
BLFS annual earnings per share is -$0.44

EPS Analysts Estimate

-$0.03
BLFS annual earnings per share is currently +1366.67% higher than the consensus analysts' forecast

EPS 1-year Change

+71.61%
BLFS annual earnings per share is up +71.61% year-on-year

EPS Sector Rank

70.53%
BLFS annual earnings per share is higher than 70.53% of companies in Healthcare sector

Profit

Gross Profit

$53.67M
BLFS annual gross profit is $53.67 million

Gross Margin

65.25%
BLFS annual gross profit margin is 65.25%

Operating Profit

-$7.13M
BLFS annual operating income is -$7.13 million

Operating Margin

-8.67%
BLFS annual operating profit margin is -8.67%

Net Income

-$20.18M
BLFS annual net profit is -$20.18 million

Net Margin

-24.54%
BLFS annual net profit margin is -24.54%

Expenses

Total Expenses

$89.38M
BLFS annual total expenses is $89.38 million

Operating Expenses

$60.80M
BLFS annual total operating expenses is $60.80 million

Cost Of Goods Sold

$28.58M
BLFS annual cost of goods sold is $28.58 million

Selling, General & Administrative Expenses

$50.15M
BLFS annual SGA is $50.15 million

Depreciation And Amortization

$8.66M
BLFS annual depreciation & amortization is $8.66 million

Interest Expense

-
BLFS annual interest expense value is unknown

Income Tax

-$38.00K
BLFS annual income tax is -$38.00 thousand

EBIT & EBITDA

EBIT

-$7.13M
BLFS annual earnings before interest & taxes is -$7.13 million

EBITDA

$1.53M
BLFS annual EBITDA is $1.53 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$399.49M
BLFS annual total assets is $399.49 million

Non Current Assets

$250.73M
BLFS annual long term assets is $250.73 million

Current Assets

$148.76M
BLFS annual total current assets is $148.76 million

Cash And Cash Equivalents

$95.39M
BLFS annual cash & cash equivalents is $95.39 million

Accounts Receivable

$9.17M
BLFS annual accounts receivable is $9.17 million

Inventory

$29.01M
BLFS annual inventory is $29.01 million

Liabilities

Total Liabilities

$50.58M
BLFS annual total liabilities is $50.58 million

Long Term Liabilities

$17.84M
BLFS annual total long term liabilities is $17.84 million

Current Liabilities

$32.73M
BLFS annual total current liabilities is $32.73 million

Accounts Payable

$3.57M
BLFS annual accounts payable is $3.57 million

Debt

Total Debt

$30.17M
BLFS annual total debt is $30.17 million

Total Debt 1-year Change

-10.8%
BLFS annual total debt is down -10.8% year-on-year

Long Term Debt

$17.72M
BLFS annual long term debt is $17.72 million

Short Term Debt

$12.45M
BLFS annual short term debt is $12.45 million

Equity & Capital

Shareholders Equity

$348.91M
BLFS annual stockholders equity is $348.91 million

Book Value

$348.91M
BLFS annual book value is $348.91 million

Retained Earnings

-$335.10M
BLFS annual retained earnings is -$335.10 million

Working Capital

$116.03M
BLFS annual working capital is $116.03 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$8.43M
BLFS annual cash flow from operations is $8.43 million

Cash From Operations 1-year Change

+167.46%
BLFS annual cash flow from operations is up +167.46% year-on-year

Cash From Investing

$58.30M
BLFS annual cash flow from investing activities is $58.30 million

Cash From Investing 1-year Change

+226.85%
BLFS annual cash flow from investing activities is up +226.85% year-on-year

Cash From Financing

-$6.78M
BLFS annual cash flow from financing activities is -$6.78 million

Cash From Financing 1-year Change

-164.04%
BLFS annual cash flow from financing activities is down -164.04% year-on-year

CAPEX

CAPEX

$3.53M
BLFS annual capital expenditures is $3.53 million

CAPEX 1-year Change

-44.73%
BLFS annual capital expenditures is down -44.73% year-on-year

Free Cash Flow

Free Cash Flow

$4.90M
BLFS annual free cash flow is $4.90 million

Free Cash Flow 1-year Change

+125.98%
BLFS annual free cash flow is up +125.98% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

65.25%
BLFS annual gross profit margin is 65.25%

Operating Margin

-8.67%
BLFS annual operating profit margin is -8.67%

Net Margin

-24.54%
BLFS annual net profit margin is -24.54%

ROA & ROE

ROA

-4.97%
BLFS annual return on assets is -4.97%

ROE

-5.88%
BLFS annual return on equity is -5.88%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
BLFS price to earnings ratio value is unknown

PE Ratio Sector Rank

-
BLFS price to earnings ratio is unknown

PB Ratio

PB Ratio

3.02
BLFS price to book ratio is 3.02

PB Ratio Sector Rank

72.66%
BLFS price to book ratio is higher than 72.66% of companies in Healthcare sector

PS Ratio

PS Ratio

12.07
BLFS price to sales ratio is 12.07

PS Ratio Sector Rank

81.43%
BLFS price to sales ratio is higher than 81.43% of companies in Healthcare sector

Enterprise value

Enterprise Value

$987.38M
BLFS enterprise value is $987.38 million

Enterprise Value Sector Rank

75.35%
BLFS enterprise value is higher than 75.35% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-222.98
BLFS EV/EBITDA is -222.98

EV/EBITDA Sector Rank

0.52%
BLFS EV/EBITDA is higher than 0.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

4.54
BLFS annual current ratio is 4.54

Quick Ratio

3.66
BLFS annual quick ratio is 3.66

Leverage

Debt To Equity

0.05
BLFS annual debt to equity ratio is 0.05

Interest Coverage Ratio

-
BLFS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
BLFS piotroski f-score is 5

Altman Z-Score

11.81
BLFS altman z-score is 11.81

Analyst ratings

Recent major analysts updates

Mar 6, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Northland Capital Markets
Outperform
Dec 19, 24 Benchmark
Buy
Dec 13, 24 Keybanc
Overweight
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 13, 24 TD Cowen
Buy
Nov 13, 24 Craig-Hallum
Buy
Sep 30, 24 HC Wainwright & Co.
Buy
Aug 12, 24 Craig-Hallum
Buy
Aug 9, 24 Northland Capital Markets
Outperform

Institutional Ownership

Similar stocks

AORT logo
Artivion (AORT)
OPK logo
OPKO Health (OPK)
ADPT logo
Adaptive Biotechnologies (ADPT)
AVAH logo
Aveanna Healthcare Holdings (AVAH)
USPH logo
US Physical Therapy (USPH)
MDXG logo
MiMedx (MDXG)
WVE logo
Wave Life Sciences (WVE)
ETNB logo
89bio (ETNB)
IOVA logo
Iovance Biotherapeutics (IOVA)
  • What is the ticker symbol for BioLife Solutions?
  • Does BioLife Solutions pay dividends?
  • What sector is BioLife Solutions in?
  • What industry is BioLife Solutions in?
  • What country is BioLife Solutions based in?
  • When did BioLife Solutions go public?
  • Is BioLife Solutions in the S&P 500?
  • Is BioLife Solutions in the NASDAQ 100?
  • Is BioLife Solutions in the Dow Jones?
  • When was BioLife Solutions's last earnings report?
  • When does BioLife Solutions report earnings?
  • Should I buy BioLife Solutions stock now?

What is the ticker symbol for BioLife Solutions?

The ticker symbol for BioLife Solutions is NASDAQ:BLFS

Does BioLife Solutions pay dividends?

No, BioLife Solutions does not pay dividends

What sector is BioLife Solutions in?

BioLife Solutions is in the Healthcare sector

What industry is BioLife Solutions in?

BioLife Solutions is in the Medical Instruments & Supplies industry

What country is BioLife Solutions based in?

BioLife Solutions is headquartered in United States

When did BioLife Solutions go public?

BioLife Solutions's initial public offering (IPO) was on November 22, 1989

Is BioLife Solutions in the S&P 500?

No, BioLife Solutions is not included in the S&P 500 index

Is BioLife Solutions in the NASDAQ 100?

No, BioLife Solutions is not included in the NASDAQ 100 index

Is BioLife Solutions in the Dow Jones?

No, BioLife Solutions is not included in the Dow Jones index

When was BioLife Solutions's last earnings report?

BioLife Solutions's most recent earnings report was on Mar 3, 2025

When does BioLife Solutions report earnings?

The next expected earnings date for BioLife Solutions is May 9, 2025

Should I buy BioLife Solutions stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page